510(k) device
ADVIA Centaur Total IgE (tIgE)
Siemens Healthcare Diagnostics, Inc. · Ige, Antigen, Antiserum, Control (DGC, Class II) · First FDA decision Jan 15, 2020, newest Jan 15, 2020Asthma
Last checked: Nov 19, 2026Source: FDA, CMS, ClinicalTrials.gov, PubMed
FDA decisions
1
510(k) pathway
Device trials
2
Naming "ADVIA Centaur"
MAUDE reports
3,203
Brand "ADVIA Centaur", since 2015
PubMed studies
493
Mentioning "ADVIA Centaur"
AI summary across all sources
Written by AI from the FDA, CMS, ClinicalTrials.gov, MAUDE and PubMed data on this page, plus web searches for payment facts.
Product review deck
A slide deck reviewing ADVIA Centaur Total IgE (tIgE)
About ten slides on the technology, clinical evidence, regulatory history and commercialization, built with AI from the data on this page and web research, with sources. Download it as PowerPoint to edit or as PDF to share.
- Executive summary and key facts
- Technology
- Clinical evidence and trials
- Regulatory history and safety
- Reimbursement, market and competition
- Risks, outlook and sources
AI-written from public data and may contain mistakes. Check each fact against its source before relying on it. Not investment, legal, reimbursement or medical advice.
FDA decisions
The newest 1 of 1 decisions filed under this name.
K193493 · Decided Jan 15, 2020 · 29 days after receipt
Device type: Ige, Antigen, Antiserum, Control (DGC) · Laboratory Medicine & Pathology
Medicare coverage
National and local coverage documents whose titles match this device or its device type. Payment add-ons (NTAP, pass-through, TCET) and likely codes are covered in the summary above.
No Medicare coverage document has a title matching this device or device type. Many devices are paid under existing codes without one.
Clinical trials
Device studies on ClinicalTrials.gov that name "ADVIA Centaur", any status and sponsor, newest update first.
- Diagnostic Sensitivity and Specificity of iStatis HBsAg Test at the Point-Of-Care Site SettingsPivotal-lookingCompleted
bioLytical LaboratoriesNot on our public-company list
NCT06368479 · 1,400 participants · Start Mar 19, 2024 · Primary completion Jul 19, 2024
Device: iStatis HBsAg Test · For: Hepatitis B; Hepatitis B Infection
Sites: Hillcrest, South Africa
Siemens Healthcare Diagnostics IncPublic (SHL.DE)
NCT00622531 · 108 participants · Start Jan 2007 · Primary completion Jul 2009
Device: BNP assay (Siemens ADVIA Centaur BNP) · For: Heart Failure
Sites: Palo Alto, California; New York, New York; Poughkeepsie, New York · 11 sites in all
Adverse event reports (MAUDE)
Reports received since 2015 naming the brand "ADVIA Centaur", and for the whole product code for context.
This brand
3,203 reports: 3,170 malfunction, 33 injury, 0 death
Whole product code DGC
6 reports: 6 malfunction, 0 injury, 0 death
Newest reports for this brand
- ADVIA Centaur XP AnalyzerMalfunction
Siemens Healthcare Diagnostics Inc.
2432235-2026-00234 · Received Oct 5, 2026 · Event dated Sep 9, 2026
Device type: Analyzer, Chemistry (Photometric, Discrete), For Clinical Use (JJE)
Device problem as coded: Low Test Results
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- ADVIA Centaur XP AnalyzerMalfunction
Siemens Healthcare Diagnostics Inc.
2432235-2026-00228 · Received Sep 25, 2026 · Event dated Sep 9, 2026
Device type: Analyzer, Chemistry (Photometric, Discrete), For Clinical Use (JJE)
Device problem as coded: Low Test Results
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
- ADVIA Centaur CP AnalyzerMalfunction
Siemens Healthcare Diagnostics Inc
2432235-2026-00224 · Received Sep 18, 2026 · Event dated Aug 24, 2026
Device type: Analyzer, Chemistry (Photometric, Discrete), For Clinical Use (JJE)
Device problem as coded: High Test Results
Patient problem as coded: No Clinical Signs, Symptoms or Conditions
2 more reports with a free account
Recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
No recall in FDA's data is linked to these FDA numbers.
Published research
The most relevant PubMed records for "ADVIA Centaur"[tiab]. The summary above synthesizes these.
- High performance of the automated ADVIA Centaur Systems SARS-CoV-2 Antigen Assay in nasopharyngeal samples with high viral load.
Ríos E, Medrano S, Alvarez M, et al. · Int Microbiol · 2023
- Maternal hypothyroidism and adverse outcomes of pregnancy.
Knøsgaard L, Andersen S, Hansen AB, et al. · Clin Endocrinol (Oxf) · 2023Research Support, Non-U.S. Gov't
- Comparison of ADVIA Centaur ultra-sensitive and high-sensitive assays for troponin I in serum.
Osredkar J, Fabjan T, Kumer K, et al. · Pract Lab Med · 2022
- Validation of the ADVIA Centaur® XP system for the determination of insulin and its application.
Xu YY, Xu SM, Li XM, et al. · Anal Biochem · 2020Randomized Controlled Trial, Validation Study
- Norethisterone interference in testosterone assays.
Jeffery J, MacKenzie F, Beckett G, et al. · Ann Clin Biochem · 2014
- Testosterone measurements in early infancy.
Tomlinson C, Macintyre H, Dorrian CA, et al. · Arch Dis Child Fetal Neonatal Ed · 2004Comparative Study
- Fourth generation assays for HIV testing.
Vallefuoco L, Mazzarella C, Portella G · Expert Rev Mol Diagn · 2016Review
- A mathematical algorithm to harmonize measurements for thyroid-stimulating hormone between instruments.
Zhou X, Liu Z, Ma Y, et al. · Clin Chim Acta · 2023
- Comparative evaluation of ADVIA Centaur® XP chemiluminescence system for screening of HBV, HCV, HIV and syphilis in Indian blood donors.
Arcot PJ, Pandey HC, Coshic P, et al. · Transfus Apher Sci · 2022
- Simultaneous determination of 24 antiepileptic drugs and their active metabolites in human plasma by UHPLC-MS/MS.
Jiang R, Zhang D, Zhao Z, et al. · J Pharm Biomed Anal · 2023
- Performance characteristics of eight estradiol immunoassays.
Yang DT, Owen WE, Ramsay CS, et al. · Am J Clin Pathol · 2004Comparative Study, Research Support, Non-U.S. Gov't
- Performance characteristics of six homocysteine assays.
La'ulu SL, Rawlins ML, Pfeiffer CM, et al. · Am J Clin Pathol · 2008Comparative Study, Evaluation Study
Other devices of this type
Also filed under product code DGC.
- Quantia IgEBiokit, S.A. · 510(k) 2023
- ImmunoCAP Total IgE Calibrator Strip/Total IgE Curve Control StripPhadia AB · 510(k) 2016
- Kenota 1 Total IgEKenota, Inc. · 510(k) 2024
- Total Immunoglobulin E (IgE)Beckman Coulter, Inc. · 510(k) 2022
- Dimension Vista Ige Flex Reagent CartridgeDade Behring, Inc. · 510(k) 2007
- K-Assay Total Ige, K-Assay Ige Calibrator Set, Models KAI-092/KAI-093CKamiya Biomedical Co. · 510(k) 2004
- LacrytestAdiatec SA · 510(k) 2004
- Immunetech Total Ige SystemImmunetech Corporation · 510(k) 2003
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.